People with CF and their Carers

An Introduction to Paravit®

Paravit® is a range of fat-soluble vitamin supplements specially formulated to the nutritional requirements of people with Cystic Fibrosis. Paravit comes in two formulations: Paravit®-CF and Paravit®-Mod and is available in both liquid form and as soft-gel capsules.

Paravit® supplements offer several advantages over standard vitamins:

  • Paravit® vitamins contain fat-soluble vitamins A, D, E and K, in higher amounts than those found in regular food supplements1
  • Paravit® combines all four vitamins in one convenient daily dose, reducing the number of alternative tablets/ capsules otherwise required
  • Paravit® is designed for optimal vitamin absorption, using Medium Chain Triglyceride (MCT) absorption technology to deliver the vitamins
  • Both Paravit®-CF and Paravit®-Mod were developed in collaboration with Cystic-Fibrosis specialist healthcare professionals

MCT absorption technology:

Most people with Cystic Fibrosis cannot absorb fat effectively from their food, including the four fat-soluble vitamins, A, D, E and K; this is especially a problem for those who do not produce enough pancreatic enzymes or bile acids for digestion.

Medium Chain Triglyceride (MCT) oil is a fat source used to “carry” the fat-soluble vitamins in Paravit® across the gut wall, to be stored (or used) in the body. Unlike more widely consumed Long Chain Triglycerides (LCT), MCT digestion and absorption is simple, as they travel passively through the gut wall, directly to the bloodstream2. They are absorbed without pancreatic enzymes or bile salts3, making Paravit® suitable for people with Cystic Fibrosis and those who are “pancreatic insufficient”.

 

Paravit®-CF

Paravit®-CF is a fat-soluble vitamin supplement specially designed for people with Cystic Fibrosis.



Paravit®-Mod

Introducing Paravit®-Mod. An all in one vitamin specially designed for Cystic-Fibrosis patients undergoing Modulator therapies.



  1. Paravit®-CF Patient information leaflet
  2. Gracey M et al. Medium Chain Triglycerides in Paediatric Practice. Archives of Disease in Childhood, 1970, 45, 445
  3. Symersky et al. The effect of equicaloric medium-chain and long-chain triglycerides on pancreas enzyme secretion. Clinical Physiology and Functional Imaging. 2002; 22:5, 307-311 https://doi.org/10.1046/j.1475-097X.2002.00435.x

 

UK-PVI-2400023 | June 2024